(Asp-Ser-Ser) 6

(Asp-Ser-Ser) 6 ((DSS) 6) is an artificially designed bone-targeting peptide. (Asp-Ser-Ser) 6 is used as a ligand to modify apoptotic extracellular vesicles (ApoEVs) in order to enhance the bone targeting and efficacy of ApoEVs in the treatment of osteoporosis. (Asp-Ser-Ser) 6 can be used for research on osteoporosis[1].

929906-72-9

(DSS) 6

12352209

Others

Others

Metabolism-protein/nucleotide metabolism

Metabolic Disease

O=C(N[C@@H](CO)C(N[C@@H](CO)C(N[C@@H](CC(O)=O)C(N[C@@H](CO)C(N[C@@H](CO)C(N[C@@H](CC(O)=O)C(N[C@@H](CO)C(N[C@@H](CO)C(N[C@@H](CC(O)=O)C(N[C@@H](CO)C(N[C@@H](CO)C(N[C@@H](CC(O)=O)C(N[C@@H](CO)C(N[C@@H](CO)C(N[C@@H](CC(O)=O)C(N[C@@H](CO)C(N[C@@H](CO)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CC(O)=O)N

C60H92N18O43

1753.47

[1]Gui L, et al. Bone-Targeting Peptide and RNF146 Modified Apoptotic Extracellular Vesicles Alleviate Osteoporosis. Int J Nanomedicine. 2024 Jan 17;19:471-488.

Room temperature

http://file.medchemexpress.com/batch_PDF/HY-P11552/

Peptides

No Development Reported